E
XORTX Therapeutics Inc. XRTX
$3.27 $0.23427.70%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 524.40K 791.10K 565.80K 523.90K 482.40K
Depreciation & Amortization 16.50K 32.00K 66.80K 21.50K 22.10K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.11M 1.49M 1.68M 2.45M 1.98M
Operating Income -1.11M -1.49M -1.68M -2.45M -1.98M
Income Before Tax -1.33M -1.69M -1.83M -2.15M -1.20M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -1.33M -1.69M -1.83M -2.15M -1.20M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -1.33M -1.69M -1.83M -2.15M -1.20M
EBIT -1.11M -1.49M -1.68M -2.45M -1.98M
EBITDA -1.11M -1.48M -1.63M -2.44M -1.96M
EPS Basic -0.67 -0.85 -0.95 -1.35 -0.83
Normalized Basic EPS -0.42 -0.53 -0.59 -0.85 -0.52
EPS Diluted -0.67 -0.85 -0.95 -1.35 -0.83
Normalized Diluted EPS -0.42 -0.53 -0.59 -0.85 -0.52
Average Basic Shares Outstanding 2.00M 2.00M 1.93M 1.59M 1.44M
Average Diluted Shares Outstanding 2.00M 2.00M 1.93M 1.59M 1.44M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings